(Q36404922)

14 August 2017

1 reference

title

Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic (English)

1 reference

14 August 2017

1 reference

Carmelo Scarpignato

1

1 reference

14 August 2017

Iva Pelosini

series ordinal

2

1 reference

14 August 2017

publication date

8 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

73 Suppl 1

1 reference

14 August 2017

page(s)

13-27

1 reference

Gastrointestinal infections

14 August 2017

cites work

1 reference

Practice guidelines for the management of infectious diarrhea

21 January 2018

1 reference

21 January 2018

Vancomycin: an update

1 reference

21 January 2018

1 reference

Pseudomembranous colitis: causes and cures

21 January 2018

1 reference

Clostridium difficile-associated diarrhea in adults

21 January 2018

1 reference

Chemistry and biology of the ramoplanin family of peptide antibiotics

21 January 2018

1 reference

Deafness Complicating Antibiotic Therapy of Hepatic Encephalopathy

21 January 2018

1 reference

In vitro activity and fecal concentration of rifaximin after oral administration

21 January 2018

1 reference

In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species

21 January 2018

1 reference

In vitro activity of rifaximin against Helicobacter pylori.

21 January 2018

1 reference

Susceptibility to rifaximin of Vibrio cholerae strains from different geographical areas

21 January 2018

1 reference

Aminoglycoside antibiotic resistance by enzymatic deactivation

21 January 2018

1 reference

Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative

21 January 2018

1 reference

The role of the gut flora in health and disease, and its modification as therapy

21 January 2018

1 reference

Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective

21 January 2018

1 reference

The use of rifampicin in staphylococcal infections--a review

21 January 2018

1 reference

Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci

21 January 2018

1 reference

Neomycin absorption in man. Studies of oral and enema administration and effect of intestinal ulceration.

21 January 2018

1 reference

Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

21 January 2018

1 reference

Drug interactions between oral contraceptives and antibiotics

21 January 2018

1 reference

Assessment of orocaecal transit time in different localization of Crohn's disease and its possible influence on clinical response to therapy

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea

21 January 2018

1 reference

In vitro activity of rifaximin, a topical rifamycin derivative, against Chlamydia trachomatis

21 January 2018

1 reference

Drug excretion into breast milk--overview

21 January 2018

1 reference

A teratological study of aminoglycoside antibiotic treatment during pregnancy.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000089776

1 reference

14 August 2017

1 reference